TERN   $5.79  1.40% Market Closed After Close 5.82 0.52%

Terns Pharmaceuticals Inc
Total Cash 225.30M
totalCashPerShare 3.202
EBITDA -107.91M
Total Debt 249.00K
quickRatio 20.566
currentRatio 21.017
Total Revenue
debtToEquity 0.114
Revenue/Share
ROA -0.25987
ROE -0.38916
grossProfits
freeCashflow -46.11M
operatingCashflow -78.99M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 279.52M
forwardPE -5.208633
floatShares 49.25M
sharesOutstanding 84.44M
sharesShort 4.35M
sharesShortPriorMonth 3.76M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.85%
Short Ratio help_outline 2.78%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 3.109
Price To Book help_outline 2.33
earningsQuarterlyGrowth
netIncomeToCommon -95.89M
trailingEps -1.32%
forwardEps -1.39%
enterpriseToEbitda -2.59
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.32 3Q 2024
institutionsCount 182
lastUpdated Nov. 7, 2024, 4:54 a.m.